Evidence map›Paper›PMID 35143012›Full record

Trial reportObesity surgery2022

Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery.

Sylke Haal, Maimoena S S Guman, Sjoerd Bruin, Ruben Schouten, Ruben N van Veen, Paul Fockens, Marcel G W Dijkgraaf, Barbara A Hutten, Victor E A Gerdes, Rogier P Voermans

Open access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Obesity surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 4 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. ASYMPTOMATIC CHOLELITHIASIS: EXPECTANT OR CHOLECYSTECTOMY. A SYSTEMATIC REVIEW.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2023
    Pooled it
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Sylke HaalDepartment of Internal Medicine, Spaarne Gasthuis, 2134 TM, Hoofddorp, the Netherlands. s.haal@amsterdamumc.nl.ORCID 0000-0001-7668-9164
Maimoena S S GumanDepartment of Internal Medicine, Spaarne Gasthuis, 2134 TM, Hoofddorp, the Netherlands.
Sjoerd BruinDepartment of Surgery, Spaarne Gasthuis, 2134 TM, Hoofddorp, the Netherlands.
Ruben SchoutenDepartment of Surgery, Flevohospital, 1315 RA, Almere, the Netherlands.
Ruben N van VeenDepartment of Surgery, OLVG, 1061 AE, Amsterdam, the Netherlands.
Paul FockensDepartment of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, 1105 AZ, Amsterdam, the Netherlands.
Marcel G W DijkgraafDepartment of Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, 1105 AZ, Amsterdam, the Netherlands.
Barbara A HuttenDepartment of Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, 1105 AZ, Amsterdam, the Netherlands.
Victor E A GerdesDepartment of Internal Medicine, Spaarne Gasthuis, 2134 TM, Hoofddorp, the Netherlands.
Rogier P VoermansDepartment of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, 1105 AZ, Amsterdam, the Netherlands.
Amsterdam University Medical Centers · NLSpaarne Ziekenhuis · NLFlevoziekenhuis · NLOLVG · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePatients who undergo bariatric surgery are at risk for developing cholesterol gallstones. We aimed to identify risk factors that are associated with symptomatic gallstone disease and gallstone formation after bariatric surgery. MATERIALS AND

methodsWe included participants of the UPGRADE trial, a multicenter randomized placebo-controlled trial on the prevention of symptomatic gallstone disease with ursodeoxycholic acid (UDCA) after bariatric surgery. The association between patient characteristics and symptomatic gallstone disease, and gallstone formation was evaluated using logistic regression analysis.

resultsOf 959 patients, 78 (8%) developed symptomatic gallstone disease within 24 months. Risk factors were the presence of a pain syndrome (OR 2.07; 95% CI 1.03 to 4.17) and asymptomatic gallstones before surgery (OR 3.15; 95% CI 1.87 to 5.33). Advanced age (OR 0.95; 95% CI 0.93 to 0.97) was protective, and UDCA prophylaxis did not reach statistical significance (OR 0.64; 95% CI 0.39 to 1.03). No risk factors were identified for gallstone formation, whereas advanced age (OR 0.98; 95% CI 0.96 to 1.00), statin use (OR 0.42; 95% CI 0.20 to 0.90), and UDCA prophylaxis (OR 0.47; 95% CI 0.30 to 0.73) all reduced the risk.

conclusionYoung patients with a preoperative pain syndrome and/or asymptomatic gallstones before bariatric surgery are at increased risk for symptomatic gallstone disease after surgery. Whether statins, either alone or in combination with UDCA prophylaxis, can further reduce the burden of gallstones after bariatric surgery should be investigated prospectively.

Indexed as

Bariatric SurgeryGallstonesObesity, MorbidHumansRisk FactorsUrsodeoxycholic AcidUrsodeoxycholic AcidGallstone formationRisk factorsSymptomatic gallstone disease

Identifiers

PMID35143012
PMCPMC8933359
OpenAlexW4211223046

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.